WithdrawnNCT02588430

PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Studying OBSOLETE: Inherited retinal disorder

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Retina Implant AG
Principal Investigator: Florian Gekeler, Prof Dr med
Katharinenhospital Stuttgart
Eligibility: 18 years · All sexes
Timeline: 2019 – 2030

Study locations (1)

Katharinenhospital Stuttgart, Stuttgart, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02588430 on ClinicalTrials.gov

Other trials for OBSOLETE: Inherited retinal disorder

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1, PHASE2NCT07408232
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
Octant, Inc.
RECRUITINGEARLY PHASE1NCT07063030
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGPHASE1, PHASE2NCT06852963
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
PYC Therapeutics
RECRUITINGPHASE1NCT06319872
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
University of Rochester
RECRUITINGPHASE1NCT06936787
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
ENROLLING BY INVITATIONNCT07056738
Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients
University Medical Center Goettingen
ACTIVE NOT RECRUITINGPHASE3NCT06388200
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Ocugen
RECRUITINGPHASE1NCT06455826
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
PYC Therapeutics

See all trials for OBSOLETE: Inherited retinal disorder →

← Back to all trials